Will These Stocks Bounce Back: Sunesis Pharmaceuticals, Inc.(SNSS), Pacific Ethanol Inc(PEIX) and Array Biopharma Inc(ARRY)?
New York, NY – GDP INSIDER – 01/21/2015.
This article discusses three companies: Sunesis Pharmaceuticals, Inc.(NASDAQ:SNSS), Pacific Ethanol Inc(NASDAQ:PEIX) and Array Biopharma Inc(NASDAQ:ARRY)
Sunesis Pharmaceuticals, Inc.(NASDAQ:SNSS) had a trading volume of 1.51 million, a figure which is 0.30 million lower than its 30-day average trading volume of 1.81 million. The stock has a return on assets (ttm) of -89.70%, return on equity (ttm) of -501.50% and return on investment (ttm) of -268.60%. Sunesis Pharmaceuticals gained 1.65% to $0.04 during yesterday’s trading, which moved the stock 146.00% above its 52-week low of $1. In a research note on Tuesday 6, analysts at BTIG Research initiated their coverage on the stock. They now have a buy rating on the stock with a price target set to $5.50.
Pacific Ethanol Inc(NASDAQ:PEIX) traded within a range of $7.78 to $8.29 during intraday trading and gained 1.60% to $0.13 per share to close the day at a new closing price of $8.25. The stock gained an additional five cents to 0.61% during afterhours trading. The stock had a trading volume of 1.50 million, which is 0.15 million greater than its 30-day average trading volume of 1.35 million, and 24.48 million shares outstanding. Recently, analysts at Zacks upgraded their rating on the stock from underperform to neutral with a price target set to $9.20, while analysts at Roth Capital initiated their ‘buy’ coverage on the shares of Pacific Ethanol Inc with a price target set to $16.
Array Biopharma Inc(NASDAQ:ARRY) jumped 2.45% to close its trading session at a closing price of $4.60. The 593.80 million market cap company, which had a trading volume of 1.46 million and 131.96 million shares outstanding, currently stands at weekly performance of -1.92%, monthly performance of -2.34% and an year-to-date performance of -2.75%. Analysts at Jefferies group and Cantor Fitzgerald hold a buy rating on the shares of Array Biopharma Inc, while analysts at Zacks hold a neutral rating on the stock with a price target set to $5.20. The stock closed the day at a beta of 1.96 and an average true range of 0.23.
HotStockGains.com provides investors and traders with trading strategies via text message and email. To obtain text message stock alerts service text the word BREAKOUT to 555888 from your cell phone.
Additionally, HotStockGains free newsletter provides market insight, tips, and trading strategies on NYSE, NASDAQ, OTCBB and PINK stocks.
Disclosure: HotStockGains is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Always seek help from a professional financial advisor (I am not one). Please visit http://hotstockgains.com/disclaimer/ for complete risks and disclosures.